CG Carlyle Group
Carlyle Group earnings company data as of 1:07 PM ET 10/30
Scheduled
1 period, newest first, nothing reported yet. Each row shows EPS above revenue.
| Period | Date | Metric | Estimate | Actual | Result |
|---|---|---|---|---|---|
| FY2026 Q3 | 5 Nov | EPS | 0.99 | — | — |
| Rev | $906.9M | — | — |
Insider trades
Open-market buys and sales by CG's executives, directors and 10% owners in the last 12 months, from their Form 4s
- None no insider bought on the open market
- $75.8M sold by 1 insider outside a trading plan
- None no planned (10b5-1) sales
-
David M. Rubenstein DirectorSale$17.1M 400,000 shares at $42.74 1.5% of stakeTraded Sep 11 Filed Sep 11
-
David M. Rubenstein DirectorSale$23.3M 500,000 shares at $46.68 1.8% of stakeTraded Mar 19 Filed Mar 20
-
David M. Rubenstein DirectorSale$35.3M 625,000 shares at $56.55 2.2% of stakeTraded Dec 10, 2025 Filed Dec 12, 2025
Also filed in the last 12 months, not counted as buying or selling: 57 stock grants, 23 share withholdings for taxes, and 5 gifts.
SEC filings
Recent issuer filings from EDGAR, 12 shown.
| Filed | Form | Detail | Links |
|---|---|---|---|
| SCHEDULE 13G/A | — | Filing Doc | |
| 10-Q | Filing Doc | ||
| 8-K | 2.02,9.01 | Filing Doc | |
| SCHEDULE 13G/A | — | Filing Doc | |
| SCHEDULE 13G/A | — | Filing Doc | |
| 8-K | 5.02,5.07,9.01 | Filing Doc | |
| 8-K | 5.02,7.01,9.01 | Filing Doc | |
| SCHEDULE 13G/A | — | Filing Doc | |
| SCHEDULE 13G/A | — | Filing Doc | |
| SCHEDULE 13G/A | — | Filing Doc | |
| 10-Q | Filing Doc | ||
| 8-K | 2.02,9.01 | Filing Doc |
No filings match this filter.
Estimates are consensus figures; SEC filings remain the official record. Not investment advice.